Other languages Immuron Limited Nasdaq

Equities

Delayed Nasdaq Other stock markets 07:40:06 21/06/2024 pm IST			5-day change	1st Jan Change
2.1 ^USD	-2.33%		-3.23%	+12.00%

05/06	Immuron Limited Appoints Jeannette Joughin as Director	CI
31/05	Immuron Limited Announces Resignation of Roger Aston as Non-Executive Director	CI

Immuron Limited Appoints Jeannette Joughin as Director	05/06
Immuron Limited Announces Resignation of Roger Aston as Non-Executive Director	31/05
Immuron Limited Announces Stephen Anastasiou Has Resigns as Non-Executive Director	03/05
Immuron's Global Sales Climb 51% in March Quarter; Shares Surge 18%	10/04
Sector Update: Health Care Stocks Gain Late Afternoon	08/03
Sector Update: Health Care	08/03
Top Midday Gainers	08/03
Top Premarket Gainers	07/03
Immuron Moving Anti-Diarrhea Drug to Phase Three Trials	07/03
Immuron Limited Announces Positive Results Support Travelan Progress to Phase 3 Clinical Trials in the US	07/03
Immuron Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Immuron Posts Record Travelan Sales in Fiscal H1	16/01
Immuron Limited Clinical Trials Update	22/12
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study	04/12
Immuron Limited Announces Travelan® Clinical Study Cohort 2 Commences	18/23/18
Immuron Reports Big Jump in Fiscal Q1 Travelan Sales	11/23/11
Immuron Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/23/30
Immuron Limited Receives TGA GMP Clearance	09/23/09
Immuron Secures Clearance for Packaging of Immunotherapy Product; Shares Surge 27%	09/23/09
Immuron Says First Patients Enrolled in Travelan Trial	25/23/25

No results for this search